Fairchem Organics Buyback 2026 vs Nureca Limited Buyback 2025

Comparison between Fairchem Organics Buyback 2026 and Nureca Limited Buyback 2025.

Buyback Details

Fairchem Organics Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Nureca Limited Buyback 2025 is a Tender Offer proposed to list at BSE, NSE.

 Fairchem Organics Ltd.Nureca Ltd.
LogoFairchem Organics Buyback 2026 LogoNureca Limited Buyback 2025 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹10 per share₹10 per share
Buyback Price₹800 per share₹330 per share
Issue Size4,25,000 shares5,80,000 shares
Issue Size (Amount)₹34.00 Crores₹19.14 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders29 : 48863,750
General Category55 : 6063,61,250

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date.3,29,093
General Category for all other Eligible Shareholders126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date.2,50,907
RegistrarMUFG Intime India Pvt.Ltd.Alankit Assignments Ltd.
Lead ManagersMotilal Oswal Investment Advisors Ltd.Mefcom Capital Markets Ltd.
Necessity of the buyback
  • The Buyback will help the Company to distribute surplus cash to its shareholders holding equity shares thereby enhancing the overall return for them
  • The Buyback, which is being implemented through the Tender Offer route as prescribed under the Buyback Regulations, would involve a reservation of up to 15% of the Equity Shares proposed to be brought back by the Company or the actual number of Equity Shares entitled as per the shareholding of small shareholders on the Record Date, whichever is higher. The Company believes that this reservation for small shareholders would benefit a significant number of the Company's public shareholders, who would be classified as 'Small Shareholders';
  • The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by reduction in the equity base of the company, thereby leading to long-term increase in shareholder's value, and
  • The Buy Back gives an option to the shareholders holding Equity Shares of the Company, to either (i) choose to participate and get cash instead of Equity Shares to be accepted under the Buy Back Offer or (ii) choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buy Back Offer, without additional investment.

The Company is undertaking the Buyback after taking into account the Company's medium-term strategic and operational cash requirements, as well as the need to return surplus funds to the members in an effective and efficient manner. The proposed Buyback will help the Company achieve the following objectives:

  1. Optimise returns to shareholders; and
  2. Enhance overall shareholders' value. 2.2 The above objectives will be achieved through the Buyback process. They may lead to reduction in outstanding Equity Shares, improvement in earnings per Equity Share and enhanced return on invested capital. The Buyback will not, in any manner, impair the Company's ability to pursue growth opportunities or meet its cash requirements for business operations and continued capital investment, as and when required.
  3. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders;
  4. The Buyback, which is being implemented through the Tender Offer route as prescribed under the Buyback Regulations, would involve a reservation of up to 15% of the Equity Shares proposed to be brought back by the Company or the actual number of Equity Shares entitled as per the shareholding of small shareholders on the Record Date, whichever is higher. The Company believes that this reservation for small shareholders would benefit a significant number of the Company's public shareholders, who would be classified as 'Small Shareholders';
  5. The Buyback may help in improving return on equity, earnings per share by reduction in the equity base in the long term, thereby leading to long-term increase in shareholders' value; and
  6. The Buyback gives an option to the Eligible Shareholders to either (A) participate in the Buyback and receive cash in lieu of their Equity Shares, which are accepted under the BuyBack offer or (B) not to participate in the Buyback offer and get a resultant increase in their percentage shareholding in the Company post the BuyBack offer, without additional investment.

Buyback Timetable

Fairchem Organics Buyback 2026 and Nureca Limited Buyback 2025 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Fairchem Organics Buyback 2026 Buyback record date is Jan 05, 2026. Nureca Limited Buyback 2025 Buyback record date is Dec 12, 2025.

 Fairchem Organics Ltd.Nureca Ltd.
Record DateJan 05, 2026Dec 12, 2025
Offer Open DateJan 08, 2026Dec 18, 2025
Offer Closure DateJan 14, 2026Dec 24, 2025
Last date for receipt of tender formsJan 14, 2026Dec 24, 2025
Finalisation of buybackJan 20, 2026Dec 30, 2025
Last Date for settlment of bidsJan 21, 2026Jan 01, 2026
Last Date for extinguishment of sharesFeb 02, 2026Jan 12, 2026

Financial Details and Other Relevent Information

Comparison of Fairchem Organics Buyback 2026 and Nureca Limited Buyback 2025 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Fairchem Organics Ltd.Nureca Ltd.
Financial

Fairchem Organics Limited Financial Information (Restated Consolidated)

Fairchem Organics Limited's revenue decreased by 13% and profit after tax (PAT) dropped by 46% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Assets401.83334.31
Total Income539.24622.61
Profit After Tax21.9740.50
Amount in ₹ Crore

Nureca Limited Financial (Restated Consolidated)

Nureca Limited's revenue increased by 19% and profit after tax (PAT) rose by 147% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Total Income122.10102.44118.43
Profit After Tax0.85-1.79-8.25
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Sep-2025 812.55 620.35 683.51
Oct-2025 818.90 740.00 763.61
Nov-2025 825.85 753.75 763.61

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2025 294.50 245.00 268.88
Jan-2025 343.60 225.85 263.56
Jan-2025 278.40 225.95 246.70
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Sep-2025 767.00 541.55 682.95
Oct-2025 827.90 745.00 764.20
Nov-2025 825.95 750.05 764.20

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2025 293.00 247.00 267.21
Jan-2025 343.00 226.84 263.74
Jan-2025 278.40 226.00 246.80

Compare with others

Compare: